Monee Thomas
Dermatology · Bellaire, TXNPI 1780021691
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 593 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations.
Across 593 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$1K
- AbbVie$1K
- Galderma Laboratories, L.p.$855
- Novartis$703
- Mayne Pharma Commercial LLC$697
- LEO Pharma Inc.$684
- plus $5K from 26 others
What the payments were for
- Food & beverage$10,02398%
- Education$1742%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 38 | $1,355 |
| AbbVie | 65 | $1,235 |
| Galderma Laboratories, L.p. | 73 | $855 |
| Novartis | 48 | $703 |
| Mayne Pharma Commercial LLC | 90 | $697 |
| LEO Pharma Inc. | 40 | $684 |
| Johnson & Johnson | 33 | $641 |
| Amgen | 22 | $466 |
| Botanix SB Inc | 3 | $382 |
| Sanofi | 14 | $318 |
| Bristol Myers Squibb | 19 | $315 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 35 | $297 |
| UCB, Inc. | 15 | $271 |
| Medimetriks Pharmaceuticals, Inc. | 7 | $255 |
| Lilly USA, LLC | 13 | $249 |
| Pfizer | 15 | $232 |
| Almirall LLC | 11 | $201 |
| E.r. Squibb & Sons, L.L.C. | 8 | $153 |
| Sanofi-aventis U.S. LLC | 3 | $123 |
| Sun Pharmaceutical Industries Inc. | 6 | $120 |
| VYNE Pharmaceuticals Inc. | 6 | $111 |
| Incyte Corporation | 5 | $106 |
| Dermira, Inc. | 5 | $89 |
| Arcutis Biotherapeutics, Inc. | 5 | $78 |
| Hill Dermaceuticals, Inc. | 3 | $58 |
| EPI Health, LLC | 3 | $48 |
| Taro Pharmaceuticals USA, Inc. | 2 | $43 |
| Sebela Pharmaceuticals Inc. | 2 | $30 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Biocon Biologics Inc | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Mission Pharmacal Company | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$561
- SOFDRA$353
- Otezla$234
- ADBRY$133
- Clindacin ETZ$120
- Neo-Synalar$120
- COSENTYX$109
- Humira$100
How this compares
$10,197 in reported general payments places this provider in the 70th percentile of 1,098 dermatology providers in Texas.
Other dermatology in Bellaire
- Craig TellerBellaire$1.3M
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
- Ross RaduskyDallas$1.2M
- Joseph MerolaDallas$1.2M
- Daniel CarrascoAustin$1.1M
- Dale SchaeferAustin$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.